Combining two heart treatments for long blocked arteries
Part of Heart & circulation clinical trials.
This study tests a new way to treat long, narrow blockages in the heart's arteries. It combines a temporary scaffold with a drug-coated balloon, which may help the artery heal without a permanent metal stent. This could be an option for people who need their artery opened but may benefit from a less permanent approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a long (more than 40 mm) blockage in a heart artery that is between 3.0 and 4.6 mm wide.
- You are stable enough for a planned heart procedure (not an emergency).
- You can take blood-thinning medicines (aspirin plus clopidogrel, ticagrelor, or prasugrel) for at least 6 months.
- You have not had heart surgery or another heart procedure on the same artery in the past year.
- You are not on kidney dialysis and your kidney function is adequate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new way to place stents in blocked heart arteries that are at a branching point. It aims to improve blood flow and reduce the risk of the blockage coming back, compared to standard methods.
This trial tests whether using a drug-coated balloon with a scaffold is better than using a scaffold alone for people with narrowed or blocked heart arteries. It looks at which method helps the artery stay open longer.
This trial tests if using advanced imaging (like OCT or IVUS) to guide placement of a newer type of stent (bioresorbable scaffold) can reduce future stent problems. It is for people with stable coronary artery disease who need a stent in a main heart artery.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
This study tests whether a drug-coated balloon (a balloon that releases medicine to prevent reblockage) is safe and effective for treating heart attacks caused by plaque erosion, where the artery is narrowed but not fully torn. It may help reduce the need for permanent stents.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.